Answers are grounded in this paper and cite their sources.
Background This study aims to compare the effects of surgical (salpingectomy) and medical (methotrexate [MTX]) treatments for ectopic pregnancy on ovarian reserve and to evaluate their relationship with anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) levels. Materials and Methods This prospective study included 76 patients diagnosed with ectopic pregnancy and a control group of 38 healthy volunteers. Patients with ectopic pregnancy were categorized into the salpingectomy (n = 38) and MTX (n = 38) groups based on clinical indications. Basal and 4-month follow-up values for AMH, FSH, and endometrial thickness were recorded. A p value of <0.05 was considered statistically significant. Results No statistically significant differences were found among the three groups in changes in AMH and FSH levels at the 4-month follow-up. However, FSH levels increased significantly postoperatively compared with baseline in the salpingectomy group (p < 0.05). In the MTX group, no significant change in AMH levels was observed following either single- or double-dose administration. The rate of pelvic free fluid was significantly higher in the salpingectomy group (68.4%) than in the MTX group (42.1%) (p = 0.038). Conclusion The findings of this study indicate that neither salpingectomy nor MTX treatments lead to a statistically significant decrease in ovarian reserve (as measured by AMH levels) at the end of a 4-month follow-up period. Although MTX treatment may offer a slight advantage in preserving hormonal balance because it carries no risk of surgical trauma or thermal injury, both treatment modalities can be considered safe in terms of future fertility.
No takes yet. Share an insight, caveat, or question.
Karapinar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: